Robuta

https://www.jci.org/articles/view/194288/figure/1 JCI - A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic... https://www.jci.org/articles/view/194288/figure/3 JCI - A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic... https://elifesciences.org/reviewed-preprints/89136 Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in... lactate transporterstellate cellsmct1hepatic https://www.jci.org/articles/view/197651/usage JCI - Usage information: Macropinocytosis inhibition attenuates pro-fibrotic responses in lung... usage informationjcimacropinocytosisinhibition https://www.biospace.com/press-releases/rosalind-franklin-university-incubator-company-announces-positive-anti-fibrotic-effects-in-lung-disease-model Rosalind Franklin University Incubator Company Announces Positive Anti-Fibrotic Effects in Lung... rosalind franklin university https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.564108/full Frontiers | Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent BCL-2 family proteins primarily work as a programmed cell death regulator, whereby multiple interactions between them determine cell survival. This explains ... clinical review https://www.jci.org/articles/view/194288/sd/2 JCI - A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1225348/full Frontiers | Arsenic exposure and lung fibrotic changes-evidence from a longitudinal cohort study... Introduction: Arsenic (As) exposure is associated with lung toxicity and we aim to investigate the effects of arsenic exposure on lung fibrotic changes. Meth... https://www.mdpi.com/2227-9059/11/6/1771 Phytochemical Profiling and Anti-Fibrotic Activities of the Gemmotherapy Bud Extract of Corylus... In this study, we aimed to explore the hepatoprotective effects of the gemmotherapy bud extract of Corylus avellana in a model of liver fibrosis on diabetic... anti fibrotic https://www.jci.org/articles/view/93560/pdf JCI - Endoplasmic reticulum stress in the pathogenesis of fibrotic disease endoplasmic reticulum stressin thejcipathogenesisfibrotic https://www.mdpi.com/1999-4923/13/4/499 UVA-Degradable Collagenase Nanocapsules as a Potential Treatment for Fibrotic Diseases Peyronie and Dupuytren are pathologies characterized by the appearance of localized fibrotic lesions in an organ. These disorders originate from an excessive... as atreatment foruvacollagenasenanocapsules https://www.jci.org/articles/view/62204/figure/1 JCI - MicroRNAs, fibrotic remodeling, and aortic aneurysms jcimicrornasfibroticremodelingaortic https://www.jci.org/articles/view/188819/pdf JCI - Wilms tumor 1 impairs apoptotic clearance of fibroblasts in distal fibrotic lung lesions https://www.jci.org/articles/view/197651/sd/3 JCI - Macropinocytosis inhibition attenuates pro-fibrotic responses in lung fibroblasts and... jcimacropinocytosisinhibitionpro https://www.jci.org/articles/view/197651/sd/4 JCI - Macropinocytosis inhibition attenuates pro-fibrotic responses in lung fibroblasts and... jcimacropinocytosisinhibitionpro https://fibronox.com/ Fibronox - Revolutionizing Treatments for Fibrotic Diseases treatments forrevolutionizingfibroticdiseases https://pmc.ncbi.nlm.nih.gov/articles/PMC10296144/ Phytochemical Profiling and Anti-Fibrotic Activities of the Gemmotherapy Bud Extract of Corylus... In this study, we aimed to explore the hepatoprotective effects of the gemmotherapy bud extract of Corylus avellana in a model of liver fibrosis on diabetic... anti fibrotic https://www.jci.org/articles/view/193793/sd/2 JCI - Macrophage transition to a myofibroblast state drives fibrotic disease in uropathogenic E.... https://www.sciencedaily.com/releases/2016/04/160413140122.htm Anti-fibrotic peptide shows early promise against interstitial lung disease | ScienceDaily The M10 peptide reduces collagen production and reverses fibrotic damage due to systemic sclerosis (SSc)-related interstitial lung disease (ILD), preclinical... interstitial lung diseaseanti fibroticpeptideshowsearly https://www.prnewswire.com/news-releases/soliton-announces-site-selected-for-clinical-trial-to-treat-fibrotic-scars-300914781.html Soliton Announces Site Selected for Clinical Trial to Treat Fibrotic Scars /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology... clinical trialsolitonannouncessiteselected https://www.biospace.com/carisma-therapeutics-presents-preclinical-proof-of-concept-data-demonstrating-the-anti-fibrotic-potential-of-engineered-macrophages-at-asgct-2024 Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic... Aug 7, 2024 - Carisma Therapeutics Inc. announced new data demonstrating preclinical proof of concept using engineered anti-fibrotic macrophages for the treatment of liver... proof of concept https://www.jci.org/articles/view/188819/ga JCI - Wilms tumor 1 impairs apoptotic clearance of fibroblasts in distal fibrotic lung lesions https://elifesciences.org/articles/45342 Cell non-autonomous functions of S100a4 drive fibrotic tendon healing | eLife Inhibition of S100a4 represents a novel anti-fibrotic target to improve tendon healing. cellnonautonomousfunctions https://www.jci.org/articles/view/93560/figure/1 JCI - Endoplasmic reticulum stress in the pathogenesis of fibrotic disease endoplasmic reticulum stressin thejcipathogenesisfibrotic https://www.frontiersin.org/research-topics/63562/the-mechanisms-of-fibrotic-disorders-and-pharmacological-therapies/magazine The Mechanisms of Fibrotic Disorders and Pharmacological Therapies | Frontiers Research Topic Fibrosis, characterized by uncontrolled extracellular matrix deposition, is a common phenomenon seen in different organs and tissues, bringing about disastrous... mechanismsfibroticdisorders https://www.adherontherapeutics.com/ Adheron Therapeutics: Transforming Care for Fibrotic and Autoimmune Adheron Therapeutics specializes in pioneering therapies targeting cell adhesion pathways to treat fibrotic and autoimmune diseases. transforming caretherapeuticsfibroticautoimmune https://pmc.ncbi.nlm.nih.gov/articles/PMC10468758/ Cytokinopathy with aberrant cytotoxic lymphocytes and pro-fibrotic myeloid response in SARS-CoV-2... Rare immune-mediated cardiac tissue inflammation can occur after vaccination, including after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular... https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2013.00159/full Frontiers | Genetic architecture of human fibrotic diseases: disease risk and disease progression Genetic studies of human diseases have identified multiple genetic risk loci for various fibrotic diseases. This has provided insights into the myriad of bio... genetic architecturedisease riskfrontiershuman https://www.jci.org/articles/view/194288/usage JCI - Usage information: A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung... https://www.wikidata.org/wiki/Q77425692 Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological... scientific article published on 01 June 1998 infiltrating ductal carcinoma https://www.jci.org/articles/view/193793/figure/3 JCI - Macrophage transition to a myofibroblast state drives fibrotic disease in uropathogenic E.... https://www.businesswire.com/news/home/20260112649752/en/Mirador-Accelerates-Multi-Asset-Clinical-Pipeline-in-Immuno-Fibrotic-Disease-Closes-%24250-Million-Series-B-with-Premier-Investors Mirador Accelerates Multi-Asset Clinical Pipeline in Immuno-Fibrotic Disease; Closes $250 Million... Mirador Therapeutics, Inc. (Mirador), a clinical-stage precision medicine company developing next-generation therapies for immune-mediated inflammatory and f... https://www.jci.org/articles/view/194288/table/1 JCI - A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic... https://www.preprints.org/manuscript/202312.1205 Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6[v1] | Preprints.org Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease of unknown origin, with a median survival time of ~3 years after diagnosis without... https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00318/full Frontiers | Novel Anti-fibrotic Therapies Fibrosis is a major player in cardiovascular disease, both as a contributor to the development of disease, as well as a post-injury response that drives prog... anti fibroticfrontiersnoveltherapies https://www.jci.org/articles/view/194288/figure/2 JCI - A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic... https://pmc.ncbi.nlm.nih.gov/articles/PMC12957090/ Exploring the anti-fibrotic effects of safflower in systemic sclerosis based on metabolomics and... Systemic sclerosis (SSc) is a complex autoimmune disease characterized by inflammation, fibrosis, and multi-organ involvement. Traditional botanical drugs have... https://www.jci.org/articles/view/193793/citations JCI - Citations to Macrophage transition to a myofibroblast state drives fibrotic disease in... https://www.preprints.org/manuscript/202506.1303 Amphiregulin in Fibrotic Diseases and Cancer[v1] | Preprints.org Fibrotic disorders pose a significant global health burden due to limited treatment options, creating an urgent need for novel therapeutic strategies.... amphiregulinfibroticdiseasescancerv1 https://www.jci.org/articles/view/93554/pdf JCI - The fibrotic tumor stroma jcifibrotictumorstroma https://www.businesswire.com/news/home/20210520005322/en/HAYA-Therapeutics-Completes-CHF-18-Million-Seed-Financing-To-Advance-Anti-fibrotic-Therapies-Targeting-Long-Non-coding-RNAs HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies... Haya closes CHF 18M Seed financing to advance discovery and development of innovative organ and cell-selective therapeutics that target lncRNAs. https://www.jci.org/articles/view/194288/figure/4 JCI - A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic... https://www.jci.org/articles/view/193793/pdf JCI - Macrophage transition to a myofibroblast state drives fibrotic disease in uropathogenic E.... https://www.preprints.org/manuscript/202310.0168 Targeting Interleukin-17 as Novel Treatment Option for Fibrotic Diseases[v1] | Preprints.org Fibrosis is the end result of persistent inflammatory responses induced by a variety of stimuli, including chronic infections, autoimmune reactions, and tissue... https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1131070/full Frontiers | Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis Background: Variable clinical courses make it challenging to predict mortality resulting from fibrotic hypersensitivity pneumonitis (HP). This study evaluate... in patientsfrontiersfibrosisscorepredicts https://www.transparencymarketresearch.com/fibrotic-bronchoscopy-market.html Fibrotic Bronchoscopy Market Insight and Trends 2030 Fibrotic Bronchoscopy Market is driven by increase in prevalence of chronic obstructive pulmonary disease, increase in incidence of bronchoscopy, increase in... market insightfibroticbronchoscopytrends2030 https://www.jci.org/articles/view/194288/citations JCI - Citations to A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in...